EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 32 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $135,000 | +75.3% | 50,000 | +100.0% | 0.22% | +64.0% |
| Q4 2015 | $77,000 | -30.6% | 25,000 | 0.0% | 0.14% | -39.3% |
| Q3 2015 | $111,000 | -61.2% | 25,000 | -50.0% | 0.22% | -39.3% |
| Q2 2015 | $286,000 | +27.7% | 50,000 | +100.0% | 0.37% | +57.7% |
| Q1 2015 | $224,000 | – | 25,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|